Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine Dihydrochloride in Atypical Depression
NCT00585585Phase 2Terminated
- Sponsor
- University of Cincinnati
- Start
- Jul 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of betahistine in major depressive disorder (MDD), sponsored by University of Cincinnati. Started Jul 2007; status: terminated.
02
Drugs
betahistine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00585585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585585.